Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | proadifen | 667484 | drug-path |
Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | proadifen | 667484 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | proadifen | 667484 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | proadifen | 667484 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | proadifen | 667484 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | proadifen | 667484 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | proadifen | 667484 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | sulfanilamide | 5333 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | sulfanilamide | 5333 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | sulfanilamide | 5333 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | sulfanilamide | 5333 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | sulfanilamide | 5333 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | sulfanilamide | 5333 | drug-path |
Adherens junction | R-HSA-451386 | map04520 | sulfanilamide | 5333 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | sulfanilamide | 5333 | drug-path |
Circadian rhythm - mammal | R-HSA-400253 | 0 | sulfanilamide | 5333 | drug-path |
Melanoma | Q9UHD0-PRO_0000015379 | map05218 | sulfanilamide | 5333 | drug-path |
Asthma | R-HSA-444620 | map05310 | sulfanilamide | 5333 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | sulfanilamide | 5333 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | sulfanilamide | 5333 | drug-path |